Iovance Biotherapeutics, Inc.

NasdaqGM:IOVA Stok Raporu

Piyasa değeri: US$2.6b

Iovance Biotherapeutics Yönetim

Yönetim kriter kontrolleri 4/4

Iovance Biotherapeutics CEO'su Frederick Vogt, Jul2017 tarihinde atandı, in görev süresi 7.33 yıldır. in toplam yıllık tazminatı $ 4.79M olup, şirket hissesi ve opsiyonları dahil olmak üzere 14.4% maaş ve 85.6% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.067% ine doğrudan sahiptir ve bu hisseler $ 1.75M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.7 yıl ve 7.5 yıldır.

Anahtar bilgiler

Frederick Vogt

İcra Kurulu Başkanı

US$4.8m

Toplam tazminat

CEO maaş yüzdesi14.4%
CEO görev süresi7.3yrs
CEO sahipliği0.07%
Yönetim ortalama görev süresi3.7yrs
Yönetim Kurulu ortalama görev süresi7.5yrs

Son yönetim güncellemeleri

Recent updates

Iovance Biotherapeutics Q3: A Beat, But A Selloff - Now A Buy Opportunity

Nov 11

Iovance Biotherapeutics: Moving To The Next Phase

Oct 03

Iovance Therapeutics: Historic Product, Tough Commercial Outlook

Sep 06

Earnings Update: Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Just Reported And Analysts Are Boosting Their Estimates

Aug 11
Earnings Update: Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Just Reported And Analysts Are Boosting Their Estimates

Iovance's Tumor-Fighting TILs Are Just Warming Up (Rating Upgrade)

Aug 11

Iovance Biotherapeutics: Amtagvi Launch Continues Upward

Jun 26

Iovance Q1 Earnings Review: Not Enough Data To Draw Conclusions On Amtagvi

May 10

Iovance Biotherapeutics: Riding The Favorable Moment Could Bring Excellent Results

Apr 09

Iovance Biotherapeutics: Initial Amtagvi Launch In Focus

Mar 25

Iovance Biotherapeutics: Amtagvi's Pioneering Approval Sets New Standards In Melanoma

Feb 20

Iovance Biotherapeutics: Preparing For Volatility Around Lifileucel's Upcoming PDUFA Date

Jan 19

Iovance Biotherapeutics Approaches Key Regulatory Milestone As Clinical Momentum Accelerates

Sep 27

Iovance submits rolling license application to FDA for skin cancer treatment lifileucel

Aug 25

Calculating The Fair Value Of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Aug 25
Calculating The Fair Value Of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Iovance Biotherapeutics falls 6% on Q2 2022 bottom line miss

Aug 04

Iovance: TIL Cell Therapy Set To Prove Itself

Jul 11

Iovance: Onward To Approval

Apr 20

Iovance Biotherapeutics: An Unproven Biopharmaceutical Company With Significant Upside

Mar 25

CEO Tazminat Analizi

Frederick Vogt'un ücretlendirmesi Iovance Biotherapeutics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$410m

Jun 30 2024n/an/a

-US$440m

Mar 31 2024n/an/a

-US$450m

Dec 31 2023US$5mUS$692k

-US$444m

Sep 30 2023n/an/a

-US$433m

Jun 30 2023n/an/a

-US$419m

Mar 31 2023n/an/a

-US$412m

Dec 31 2022US$5mUS$650k

-US$396m

Sep 30 2022n/an/a

-US$390m

Jun 30 2022n/an/a

-US$376m

Mar 31 2022n/an/a

-US$358m

Dec 31 2021US$8mUS$471k

-US$342m

Sep 30 2021n/an/a

-US$311m

Jun 30 2021n/an/a

-US$284m

Mar 31 2021n/an/a

-US$265m

Dec 31 2020US$3mUS$418k

-US$260m

Sep 30 2020n/an/a

-US$255m

Jun 30 2020n/an/a

-US$246m

Mar 31 2020n/an/a

-US$230m

Dec 31 2019US$2mUS$398k

-US$198m

Sep 30 2019n/an/a

-US$167m

Jun 30 2019n/an/a

-US$151m

Mar 31 2019n/an/a

-US$134m

Dec 31 2018US$514kUS$375k

-US$124m

Sep 30 2018n/an/a

-US$117m

Jun 30 2018n/an/a

-US$105m

Mar 31 2018n/an/a

-US$98m

Dec 31 2017US$860kUS$326k

-US$92m

Tazminat ve Piyasa: Frederick 'ın toplam tazminatı ($USD 4.79M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 6.56M ).

Tazminat ve Kazançlar: Frederick 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Frederick Vogt (50 yo)

7.3yrs

Görev süresi

US$4,794,680

Tazminat

Dr. Frederick G. Vogt, PhD, Esq., JD, serves as an Interim CEO & President at Iovance Biotherapeutics, Inc. since June 19, 2021 and is its Director since June 11, 2024. He has been the General Counsel at I...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Frederick Vogt
Interim CEO7.3yrsUS$4.79m0.067%
$ 1.7m
Jean-Marc Bellemin
CFO, Principal Accounting Officer & Treasurer3.9yrsUS$1.71m0.0096%
$ 250.9k
Igor Bilinsky
Chief Operating Officer3.7yrsUS$1.59m0.018%
$ 477.1k
Friedrich Graf Finckenstein
Chief Medical Officer5.3yrsUS$1.77m0.020%
$ 519.1k
Sara Pellegrino
Vice President of Investor Relations & Public Relationsno dataVeri yokVeri yok
Tracy Winton
Executive Vice President of Human Resources2.6yrsVeri yokVeri yok
Howard Johnson
Chief Business Officer5.7yrsVeri yokVeri yok
Raj Puri
Executive VP of Regulatory Strategy & Translational Medicine2.7yrsVeri yokVeri yok
Brian Shew
Senior VP & Head of Digital and Information Technology2.6yrsVeri yokVeri yok
Kevin Smyth
Executive Vice President of Quality3.8yrsVeri yokVeri yok
Hequn Yin
Senior Vice President of Research2.6yrsVeri yokVeri yok
Brian Gastman
Executive Vice President of Medical Affairs1.3yrsVeri yokVeri yok

3.7yrs

Ortalama Görev Süresi

54.5yo

Ortalama Yaş

Deneyimli Yönetim: IOVA 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.7 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Frederick Vogt
Interim CEOless than a yearUS$4.79m0.067%
$ 1.7m
Mario Sznol
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Wayne Rothbaum
Independent Director8.4yrsUS$240.00k9.21%
$ 240.0m
Michael Weiser
Independent Director6.7yrsUS$744.99k0.046%
$ 1.2m
Jeffrey Weber
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Patrick Hwu
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Ryan Maynard
Independent Director9.8yrsUS$489.99k0.0025%
$ 64.1k
Iain Dukes
Independent Chairman of the Board8.3yrsUS$933.48k0.018%
$ 461.8k
James Mule
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Athena Countouriotis
Independent Director5.4yrsUS$489.99k0%
$ 0
Cassian Yee
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Daniel Powell
Member of Scientific Advisory Boardno dataVeri yokVeri yok

7.5yrs

Ortalama Görev Süresi

58.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: IOVA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.5 yıldır).